A phase II study evaluating pharmacokinetics and dosimetry of 177Lu-PSMA-617 radioligand therapy in Chinese participants with progressive metastatic castration-resistant prostate cancer.
Saved in:
| Title: | A phase II study evaluating pharmacokinetics and dosimetry of 177Lu-PSMA-617 radioligand therapy in Chinese participants with progressive metastatic castration-resistant prostate cancer. |
|---|---|
| Authors: | Shi, Hongcheng1 (AUTHOR), Guo, Jianming2 (AUTHOR), Fan, Wei3 (AUTHOR), Li, Yonghong4 (AUTHOR), Huang, Rui5 (AUTHOR), Dong, Qiang6 (AUTHOR), Yang, Zhi7 (AUTHOR), Yang, Yong8 (AUTHOR), Wang, Xinlu9 (AUTHOR), Gu, Di10 (AUTHOR), Huo, Li11 (AUTHOR), Ji, Zhigang12 (AUTHOR), Wang, Feng13 (AUTHOR), Xu, Danfeng14 (AUTHOR), Jiang, Zhiqiang15 (AUTHOR), Li, Haifu16 (AUTHOR), Li, Jialu17 (AUTHOR), Li, Runqin18 (AUTHOR), Qi, Luyuan19 (AUTHOR), Wang, Jing20 (AUTHOR) 13909245902@163.com |
| Source: | EJNMMI Research. 3/1/2026, Vol. 16 Issue 1, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
